Generative AI Startups to Watch in Healthcare Life Sciences
, Co-Founder and CEO, Innophore
, Senior Director Data Science, Relation Therapeutics
, ML Specialist, Etcembly
, Student Intern, Healthcare AI Startups, NVIDIA
, IT Director, Insilico Medicine
, CEO, Peptone
, Director of Machine Learning, Alchemab Therapeutics, Ltd.
, CEO, Alpenglow Biosciences
, Ecosystem Business Development, HCLS (Startups and Consulting Partners) , NVIDIA
, Co-Founder and CEO, Entos
, Solutions Architect, Certara, Vyasa
, Head of R&D, Healthcare and Life Sciences, Quantiphi, Inc.
Highly Rated
More than $50 billion poured into healthcare life sciences (HCLS) startups over the past two years (Source: CBInsights). Imaging, instruments, and digital health startups are using generative models to create synthetic data for rare diseases, augment surgical scenes in operating room, and provide medical reports for personalized treatment plans. AI for biopharma, or TechBio, startups was the only segment in HCLS that doubled its funding year-over-year in 2022 (Source: SVB). TechBio startups have also started using generative AI and large language model approaches to predict protein structures and properties, and more.
Join NVIDIA Global Healthcare AI Startups Lead Renee Yao, who looks after 2,000 HCLS startups globally, who will share more about what to watch in generative AI in startups. She'll cover generative AI’s current state, challenges, and opportunities. After that, 10 generative AI TechBio startups will finish with 10-minute lightning rounds on how they're using generative AI to disrupt the industry.